Rare diseases
Investigational molecules
Locations
Rue Du Rhone 65, 1204
T.O.A.D. Oncology S.A. focuses on metastatic castration-resistant prostate cancer, with particular attention to disease settings in which PSMA-expressing tumors are being targeted for treatment.
The sponsor’s current research activity is centered on therapeutic development for advanced prostate malignancy, reflecting interest in treatment options for difficult-to-manage androgen-resistant disease.
T.O.A.D. Oncology S.A. runs clinical trials in conditions such as Hormone-refractory prostate cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
